Fred Hassan

BBIO

Fred Hassan serves as Director at BridgeBio Pharma, Inc. (BBIO). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$273.4K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$273.4K

Companies Traded

BBIO

Active Period

Dec 2021

1 total trades

Most Recent

Buy BBIO

Dec 29, 2021 · $273.4K

Fred Hassan's Insider Trading at BridgeBio Pharma, Inc. (BBIO)

Buys

1 · $273.4K

Sells

0 · $0.00

Total Shares Bought

19,300

Total Shares Sold

BBIO Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 29, 2021↗	Buy	19,300	$14.17	$273.4K	0

Related Insiders

Hannah Valantine

director

BBIOSell · Mar 10, 2026

Andrea Ellis

director

BBIOSell · Mar 4, 2026

Maricel Apuli

officer: Chief Accounting Officer

BBIOSell · Feb 26, 2026

Neil Kumar

Chief Executive Officer

BBIOSell · Feb 19, 2026

Neil Kumar

director, officer: Chief Executive Officer

BBIOSell · Feb 19, 2026

Randal W. Scott

Director

BBIOSell · Feb 17, 2026

Thomas Trimarchi

President and CFO

BBIOSell · Feb 17, 2026

Thomas Trimarchi

officer: President and CFO

BBIOSell · Feb 17, 2026

Explore More Insider Trading Data

BBIO Insider Trading Activity

View all insider trades at BridgeBio Pharma, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity